Scientific and technological services, namely scientific research and development; laboratory research services in the field of chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; medical and pharmacological research services; scientific research, namely, analysis and measurement of substances; analysis and measurement of molecules and characteristics; bioanalysis services; scientific imaging services; biochemical analysis; scientific research and development services; medical research; research and development in the fields of immunology, genetic conditions, oncology, immuno-oncology, ophthalmology, haematology, neurology, respiratory diseases, metabolic conditions, infectious diseases and cardiovascular diseases; pharmaceutical research and development services; biological research and analysis; biomedical research services; biotechnology research; biotechnology research, namely, biotechnology testing; chemical research and analysis; research and development of new products for others in the biotechnical, biomedical and pharmaceutical fields; research and development in the pharmaceutical field; research and development of vaccines and medicines; research and development services in the field of antibodies; research and development services in the field of antibody technology; research and development services in the field of immunology; medical laboratory services; research of pharmaceuticals; research relating to molecular sciences; research relating to pharmaceuticals; biopharmaceutical research, development and testing services; drug discovery services; drug development services; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; research and development of molecules for therapeutic purposes; consultancy, advisory and/or information services in relation to all the aforesaid services

Class [005]
Pharmaceutical Products

Pharmaceutical and veterinary preparations for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; biopharmaceutical preparations for treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; chemical, biochemical and biological preparations for medical and veterinary purposes for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; reagents for medical use, namely reagents for in-vitro laboratory use cells for medical or clinical use, namely cells, cell lines, and cell cultures for use in the production of proteins for therapeutic use; reagents for medical use; biological reagents for medical use; therapeutic antibodies; vaccines

Mark Details

Serial Number

No 79294792

Mark Type

No Service Mark

Attorney Docket Number

No 60895-539468

44D Filed

44D Current

44E filed

44E Current

66A Filed

Yes

66A Current

Yes

Current Basis

No Basis

Legal History

Status Date	Action Taken
07^th Oct 2023	CHANGE OF NAME/ADDRESS REC'D FROM IB
14^th Feb 2022	FINAL DECISION TRANSACTION PROCESSED BY IB
24^th Jan 2022	FINAL DISPOSITION PROCESSED
24^th Jan 2022	FINAL DISPOSITION NOTICE SENT TO IB
10^th Nov 2021	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10^th Aug 2021	REGISTERED-PRINCIPAL REGISTER
30^th May 2021	NOTIFICATION PROCESSED BY IB
25^th May 2021	PUBLISHED FOR OPPOSITION
25^th May 2021	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10^th May 2021	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

OMASS

Classification Information

Class [042]Computer & Software Services & Scientific Services

Class [005]Pharmaceutical Products